Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
Cantor Fitzgerald says 15% of biotech companies down 40% or more
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
Cantor Fitzgerald Starts Bicara Therapeutics Inc (BCAX) at Overweight
-
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering
